PD-L1 gene expression was highest in triple-negative breast cancer, where 70% of tissues showed >2-fold change, followed by Her-2+ (66%), Luminal B (52%), and Luminal A (50%). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.